| Tracking the evolution of non–small-cell lung cancer M Jamal-Hanjani, GA Wilson, N McGranahan, NJ Birkbak, TBK Watkins, ... New England Journal of Medicine 376 (22), 2109-2121, 2017 | 2386 | 2017 |
| Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution C Abbosh, NJ Birkbak, GA Wilson, M Jamal-Hanjani, T Constantin, ... Nature 545 (7655), 446-451, 2017 | 1869 | 2017 |
| Allele-specific HLA loss and immune escape in lung cancer evolution N McGranahan, R Rosenthal, CT Hiley, AJ Rowan, TBK Watkins, ... Cell 171 (6), 1259-1271. e11, 2017 | 1301 | 2017 |
| Fc effector function contributes to the activity of human anti-CTLA-4 antibodies FA Vargas, AJS Furness, K Litchfield, K Joshi, R Rosenthal, E Ghorani, ... Cancer cell 33 (4), 649-663. e4, 2018 | 596 | 2018 |
| Fc-optimized anti-CD25 depletes tumor-infiltrating regulatory T cells and synergizes with PD-1 blockade to eradicate established tumors FA Vargas, AJS Furness, I Solomon, K Joshi, L Mekkaoui, MH Lesko, ... Immunity 46 (4), 577-586, 2017 | 461 | 2017 |
| Cisplatin in the modern era: The backbone of first-line chemotherapy for non-small cell lung cancer DA Fennell, Y Summers, J Cadranel, T Benepal, DC Christoph, R Lal, ... Cancer treatment reviews 44, 42-50, 2016 | 402 | 2016 |
| Tracking genomic cancer evolution for precision medicine: the lung TRACERx study M Jamal-Hanjani, A Hackshaw, Y Ngai, J Shaw, C Dive, S Quezada, ... PLoS biology 12 (7), e1001906, 2014 | 327 | 2014 |
| Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma L Au, E Hatipoglu, MR de Massy, K Litchfield, G Beattie, A Rowan, ... Cancer cell 39 (11), 1497-1518. e11, 2021 | 198 | 2021 |
| Pulmonary venous circulating tumor cell dissemination before tumor resection and disease relapse F Chemi, DG Rothwell, N McGranahan, S Gulati, C Abbosh, SP Pearce, ... Nature medicine 25 (10), 1534-1539, 2019 | 194 | 2019 |
| The evolution of lung cancer and impact of subclonal selection in TRACERx AM Frankell, M Dietzen, M Al Bakir, EL Lim, T Karasaki, S Ward, ... Nature 616 (7957), 525-533, 2023 | 177 | 2023 |
| Pembrolizumab in patients with non-small-cell lung cancer of performance status 2 (PePS2): a single arm, phase 2 trial G Middleton, K Brock, J Savage, R Mant, Y Summers, J Connibear, ... The Lancet Respiratory Medicine 8 (9), 895-904, 2020 | 165 | 2020 |
| Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: phase III randomized LUX-Lung 5 trial M Schuler, JCH Yang, K Park, JH Kim, J Bennouna, YM Chen, C Chouaid, ... Annals of Oncology 27 (3), 417-423, 2016 | 163 | 2016 |
| Antibodies against endogenous retroviruses promote lung cancer immunotherapy KW Ng, J Boumelha, KSS Enfield, J Almagro, H Cha, O Pich, T Karasaki, ... Nature 616 (7957), 563-573, 2023 | 154 | 2023 |
| The National Lung Matrix Trial of personalized therapy in lung cancer G Middleton, P Fletcher, S Popat, J Savage, Y Summers, A Greystoke, ... Nature 583 (7818), 807-812, 2020 | 149 | 2020 |
| The evolution of non-small cell lung cancer metastases in TRACERx M Al Bakir, A Huebner, C Martínez-Ruiz, K Grigoriadis, TBK Watkins, ... Nature 616 (7957), 534-542, 2023 | 123 | 2023 |
| Effect of temozolomide on central nervous system relapse in patients with advanced melanoma MJ Paul, Y Summers, AH Calvert, G Rustin, MH Brampton, N Thatcher, ... Melanoma research 12 (2), 175-178, 2002 | 115 | 2002 |
| PD‐L1 testing for lung cancer in the UK: recognizing the challenges for implementation IA Cree, R Booton, P Cane, J Gosney, M Ibrahim, K Kerr, R Lal, ... Histopathology 69 (2), 177-186, 2016 | 113 | 2016 |
| AC133+ G0 Cells from Cord Blood Show a High Incidence of Long‐Term Culture–Initiating Cells and a Capacity for More Than 100 Million‐Fold Amplification of … YJ Summers, CM Heyworth, EA De Wynter, CA Hart, J Chang, NG Testa Stem Cells 22 (5), 704-715, 2004 | 81 | 2004 |
| The effect of resistance inspiratory muscle training in the management of breathlessness in patients with thoracic malignancies: a feasibility randomised trial A Molassiotis, A Charalambous, P Taylor, Z Stamataki, Y Summers Supportive Care in Cancer 23, 1637-1645, 2015 | 76 | 2015 |
| Representative sequencing: unbiased sampling of solid tumor tissue K Litchfield, S Stanislaw, L Spain, LL Gallegos, A Rowan, D Schnidrig, ... Cell reports 31 (5), 2020 | 71 | 2020 |
